Aktie A2PNNV GX ACQU
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen GX ACQU Nasdaq

Aktien

A2PNNV

US36251A2069

GXGXU

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
GX Acquisition : Clinical pipeline includes multiple clinical stage programs including acute myeloid leukemia (AML) and glioblastoma multiforme (GBM), with a total of five clinical programs expected by 1H 2022 (Form 8-K)
Celularity Closes Merger With GX Acquisition Corp
Celularity Inc. completed the acquisition of GX Acquisition Corp. in a reverse merger transaction.
GX Acquisition : Submission of Matters to a Vote of Security Holders (Form 8-K)
GX Acquisition Corp. Approves Elections of Nine Directors
GX ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)
GX Acquisition Corp.(NasdaqCM:GXGX) dropped from NASDAQ Composite Index
GX Acquisition : Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States (Form 8-K)
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
GX Acquisition : Celularity Announces Expansion of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Phase 1 Trial in Patients with Acute Myeloid Leukemia (Form 8-K)
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
GX ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Gx Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021
GX ACQUISITION : 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
GX ACQUISITION CORP. : Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
GX Acquisition Corp. : Announces Shareholder Approval of Extension Proposal
GX Acquisition : Announces Additional Contributions to Trust Account (Form 8-K)
GX ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
GX Acquisition Corp. : Announces Additional Contributions to Trust Account
GX Acquisition : Celularity to leverage Palantir’s next generation software and computational capabilities with their deep cellular data set to accelerate research and development activities
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PNYJ Aktie
  4. A2PNNV Aktie
  5. Nachrichten GX ACQU
  6. Andere Sprachen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT